Systemic lupus erythematosus (SLE) and mixed connective tissue disease (MCTD) are characterized by the presence of autoantibodies against small nuclear ribonucleoprotein (SnRNP). In these diseases autoantibodies mediate host cell injury. The investigator proposes that B-cell autoantibody production is under the control of T-cell help in these diseases. This is supported by studies in animal models of SLE, in which depletion of CD4+ T-cells has therapeutic benefit, and recently autoantibody production to the RNP antigens has been found to have HLA DR4 and DR2 associations, implying control by T-cells restricted to these MHC alleles. The investigator proposes to analyze the hypothesis that Sn RNP reactive T-cells provide help for anti-Sm RNP autoantibody producing B-cells and that these T-cells play a role in the immunopathogenesis of SLE and MCTD. Therefore, in Aim I, the investigator will determine if Sm reactive human T-cell clones can provide help to anti-Sm autoantibody production and determine the cytokines produced by such Sm reactive T-cells.
In Aim II, the investigator will characterize the TCR Va and Vb gene segment usage and CDR3 sequences of human T-cell clones specific for the B and D polypeptides of Sm antigens.
In Aim III, the T-cell epitopes of the B and D polypeptides will be mapped using overlapping peptides, and, finally, in aim IV, the MHC restriction of the T-cell clones will be determined using transfections of a variety of HLA MHC class II alleles, notably those encoding HLR DR2.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR043308-03
Application #
2871613
Study Section
Immunological Sciences Study Section (IMS)
Program Officer
Serrate-Sztein, Susana
Project Start
1997-02-01
Project End
2002-01-31
Budget Start
1999-02-01
Budget End
2000-01-31
Support Year
3
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Missouri-Columbia
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
112205955
City
Columbia
State
MO
Country
United States
Zip Code
65211
Ascherman, D P; Zang, Y; Fernandez, I et al. (2018) An Autoimmune Basis for Raynaud's Phenomenon: Murine Model and Human Disease. Arthritis Rheumatol 70:1489-1499
Mesa, A; Fernandez, M; Wu, W et al. (2017) Can SLE classification rules be effectively applied to diagnose unclear SLE cases? Lupus 26:150-162
Carpintero, M F; Martinez, L; Fernandez, I et al. (2015) Diagnosis and risk stratification in patients with anti-RNP autoimmunity. Lupus 24:1057-66
Zang, YunJuan; Martinez, Laisel; Fernandez, Irina et al. (2014) Conservation of pathogenic TCR homology across class II restrictions in anti-ribonucleoprotein autoimmunity: extended efficacy of T cell vaccine therapy. J Immunol 192:4093-102
Somarelli, J A; Mesa, A; Rodriguez, R et al. (2011) Epitope mapping of the U1 small nuclear ribonucleoprotein particle in patients with systemic lupus erythematosus and mixed connective tissue disease. Lupus 20:274-89
Trivedi, Sapna; Zang, YunJuan; Culpepper, Schartess et al. (2010) T cell vaccination therapy in an induced model of anti-RNP autoimmune glomerulonephritis. Clin Immunol 137:281-7
Greidinger, Eric L; Zang, Yunjuan; Fernandez, Irina et al. (2009) Tissue targeting of anti-RNP autoimmunity: effects of T cells and myeloid dendritic cells in a murine model. Arthritis Rheum 60:534-42
Greidinger, Eric L; Zang, Yun Juan; Jaimes, Kimberly et al. (2008) CD4+ T cells target epitopes residing within the RNA-binding domain of the U1-70-kDa small nuclear ribonucleoprotein autoantigen and have restricted TCR diversity in an HLA-DR4-transgenic murine model of mixed connective tissue disease. J Immunol 180:8444-54
Maldonado, Marcos E; Perez, Magdalena; Pignac-Kobinger, Judith et al. (2008) Clinical and immunologic manifestations of mixed connective tissue disease in a Miami population compared to a Midwestern US Caucasian population. J Rheumatol 35:429-37
Hoffman, Robert W (2007) T cells and the loss of immunologic tolerance in Sjogren's syndrome and systemic lupus erythematosus. Arthritis Rheum 56:3180-2

Showing the most recent 10 out of 31 publications